Biodyne Co Ltd
KOSDAQ:314930
Gross Margin
Gross Margin shows how much money a company keeps from each dollar of sales after paying for the products it sells. It tells how profitable the company`s core business is before other expenses.
Gross Margin shows how much money a company keeps from each dollar of sales after paying for the products it sells. It tells how profitable the company`s core business is before other expenses.
Peer Comparison
| Country | Company | Market Cap |
Gross Margin |
||
|---|---|---|---|---|---|
| KR |
B
|
Biodyne Co Ltd
KOSDAQ:314930
|
420B KRW |
Loading...
|
|
| US |
|
Abbott Laboratories
NYSE:ABT
|
195.3B USD |
Loading...
|
|
| US |
|
Intuitive Surgical Inc
NASDAQ:ISRG
|
173.5B USD |
Loading...
|
|
| US |
|
Stryker Corp
NYSE:SYK
|
143.3B USD |
Loading...
|
|
| IE |
|
Medtronic PLC
NYSE:MDT
|
130.9B USD |
Loading...
|
|
| US |
|
Boston Scientific Corp
NYSE:BSX
|
112.3B USD |
Loading...
|
|
| DE |
|
Siemens Healthineers AG
XETRA:SHL
|
45.8B EUR |
Loading...
|
|
| US |
|
Becton Dickinson and Co
NYSE:BDX
|
50.7B USD |
Loading...
|
|
| US |
|
IDEXX Laboratories Inc
NASDAQ:IDXX
|
50.4B USD |
Loading...
|
|
| US |
|
Edwards Lifesciences Corp
NYSE:EW
|
44.4B USD |
Loading...
|
|
| US |
|
Resmed Inc
NYSE:RMD
|
36.6B USD |
Loading...
|
Market Distribution
| Min | -646.5% |
| 30th Percentile | 12.8% |
| Median | 19.7% |
| 70th Percentile | 32.2% |
| Max | 54 001.3% |
Other Profitability Ratios
Biodyne Co Ltd
Glance View
Biodyne Co., Ltd. engages in the development of cancer diagnosis solutions. The company is headquartered in Seoul, Seoul and currently employs 26 full-time employees. The company went IPO on 2021-03-17. The firm produces and sells LBC diagnostic equipment and diagnostic reagent kits. The firm's LBC equipment include PATHPLORER AUTO, PATHPLORER 4.7, PATHPLORER 4.63 and PATHPLORER ECO. The firm sells its products in domestic and overseas markets such as Japan, Russia, Portugal and Thailand.
See Also
Gross Margin is calculated by dividing the Gross Profit by the Revenue.
The current Gross Margin for Biodyne Co Ltd is 60.6%, which is above its 3-year median of 48.4%.
Over the last 3 years, Biodyne Co Ltd’s Gross Margin has increased from 33.3% to 60.6%. During this period, it reached a low of 13.9% on Mar 31, 2024 and a high of 77.8% on Mar 31, 2023.
